Company
Edwards Lifesciences Corporation
Headquarters: Irvine, CA, United States
Founded: 1958
Employees: 15,700
CEO: Mr. Michael A. Mussallem
Market Cap
$44.59 Billion
USD as of Jan. 1, 2024
Edwards Lifesciences Corporation Categories
United States Healthcare Medical DevicesUnited States Healthcare United States Medical Devices
Company Description
Edwards Lifesciences Corporation is a medical technology company specialized in artificial heart valves and hemodynamic monitoring. Edwards Lifesciences designs, manufactures, and markets surgical valve technologies, transcatheter heart valves, transcatheter mitral and tricuspid therapies, and critical care catheters.
Top Competitors by Market Capitalization
Industry: Medical Devices
| Company | Market Cap (USD) |
|---|---|
| Abbott | $192.67 B |
| Stryker Corporation | $113.24 B |
| Medtronic | $111.60 B |
| Boston Scientific Corporation | $85.22 B |
| Shenzhen Mindray Bio-Medical Electronics Co. Ltd | $49.33 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
Edwards Lifesciences Corporation has the following listings and related stock indices.
Stock: NYSE: EW wb_incandescent
Stock: BMV: EW wb_incandescent
Stock: Bovespa: E1WL34 wb_incandescent
Stock: FSX: EWL wb_incandescent
Stock: XETR: EWL wb_incandescent
Product & Services
Heart valves Critical care technology Cardiac surgery technology
Key People
Michael A. Mussallem (Chairman & CEO)
Financials
Revenue: $5.2 billion (2021)